The identification of the cellular origins of sF11R and ANXA5 and the determination of the impact of thrombotic and inflammatory factors on sF11R/ANXA5 association in T2DM warrant further investigation. This evidence concerns the gene ANXA5 and type 2 diabetes mellitus.